Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...
A refined liquid biopsy that accounts for age-related background mutations has enabled clinicians to identify patients with ...
TARA-002 demonstrates high complete response rates in BCG-naïve NMIBC patients, with 72% achieving CR and 50% maintaining it at 12 months. The treatment involves six weekly bladder instillations, ...
Protara’s lead candidate, TARA-002, has demonstrated durable complete response (CR) rates in a single-arm Phase II trial in Bacillus Calmette-Guérin (BCG)-naïve non-muscle invasive bladder cancer ...
Clinical and genomic correlates of brain metastases in small cell carcinoma of the bladder. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results